Myo-inositol + Clomiphene Citrate
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Ovulation Induction
Conditions
Ovulation Induction, Polycystic Ovary Syndrome, Clomiphene, Inositol
Trial Timeline
Jul 2, 2020 → Jan 31, 2022
NCT ID
NCT04306692About Myo-inositol + Clomiphene Citrate
Myo-inositol + Clomiphene Citrate is a approved stage product being developed by Richter Gedeon for Ovulation Induction. The current trial status is terminated. This product is registered under clinical trial identifier NCT04306692. Target conditions include Ovulation Induction, Polycystic Ovary Syndrome, Clomiphene.
What happened to similar drugs?
2 of 4 similar drugs in Ovulation Induction were approved
Approved (2) Terminated (1) Active (2)
🔄SHR7280；Ganirelix Acetate Injection simulant + SHR7280 simulant； Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
Hype Score Breakdown
Clinical
20
Activity
0
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04306692 | Approved | Terminated |
Competing Products
13 competing products in Ovulation Induction